Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ON-DEMAND WEBINARS
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
Given the essential role of sleep in overall quality of life and its link to various chronic conditions, accurately measuring sleep is crucial for developing patient-centric therapies and enhancing public health.
Chief Scientific Officer Christine Guo, Ph.D., provides key insights into DHTs aimed at empowering study teams to strategically integrate these technologies into their clinical development initiatives.
AI, sensors, and evolving regulations are redefining digital health—driving data insights, sensor-based endpoints, and regulatory pathways that shape the future of clinical research.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1342154721 doctors]( "Why Your eTMF Needs Role-Based Access")
Why Your eTMF Needs Role-Based AccessDiscover how role-based access controls can offer a way for clinical teams to answer the tough questions from regulators, investors, and other parties.
-
![GettyImages-1173740575 computer research data]( "Deconstructing Central Rating In Clinical Trials")
Deconstructing Central Rating In Clinical TrialsAnalyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this
-
![GettyImages-1447084050 data]( "Digital/Hybrid Trials Deliver Greater ROI Than Traditional Trials")
Digital/Hybrid Trials Deliver Greater ROI Than Traditional TrialsIn this paper, Tufts CSDD outlines why and how modernized clinical trials can drive greater savings (up to $40,000,000 per study) than traditional trials.
-
![GettyImages-1416816620 medical records, RWE]( "Top HEOR Trends")
Top HEOR TrendsReal-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.
-
![GettyImages-1413332879 diabetes]( "EDC Selected To Support Biotech Advances In Diabetes")
EDC Selected To Support Biotech Advances In DiabetesFind out why one leading biotechnology company keeps choosing this eClinical technologies and services provider for EDC assistance.
-
![Checking prescription on smartphone-GettyImages-1719535353]( "Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data")
Wearable Data Is Only Useful If It's There: Helping You Collect Your Study DataNew, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.
-
![GettyImages-1357084676 wearables]( "5 Important Questions To Ask Your Wearable Technology Partner")
5 Important Questions To Ask Your Wearable Technology PartnerDiscuss these questions with any wearable technology partner to establish a solid foundation for a successful collaboration that maximizes the potential of wearable DHTs in your clinical research endeavors.
-
![gettyimages-1154110666 decentralized trials]( "You Don't Have To Digitize Everything, You Just Have To Start")
You Don't Have To Digitize Everything, You Just Have To StartFeeling left behind by the sudden digitization of clinical trials? Decentralized clinical trials can be adapted to best serve the patient population, condition, or therapy you’re investigating.
-
![data-cleaning-clinical-trialls]( "AI In Clinical Trials: Practical Use Cases For Data Management")
AI In Clinical Trials: Practical Use Cases For Data ManagementAI is improving daily data management with automation, faster issue detection, and smarter reviews. This piece outlines practical use cases and what teams need to enable real, sustainable adoption.
-
![Scientists Examining Data GettyImages-1346675624]( "How Paper And Electronic Source Data Meet ALCOA-C Principles")
How Paper And Electronic Source Data Meet ALCOA-C PrinciplesAccording to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
RECENT NEWSLETTERS
- 03.07.26 -- February's Best In Clinical Tech — AI, eTMF & More
- 03.05.26 -- Is Your Legacy EDC Holding Back AI In Clinical Trials?
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
